- Home
- KVYO vs PCVX Comparison
KVYO vs PCVX Comparison
Compare KVYO & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KVYO
- PCVX
- Stock Information
- Founded
- KVYO 2012
- PCVX 2013
- Country
- KVYO United States
- PCVX United States
- Employees
- KVYO N/A
- PCVX N/A
- Industry
- KVYO
- PCVX Biotechnology: Pharmaceutical Preparations
- Sector
- KVYO
- PCVX Health Care
- Exchange
- KVYO Nasdaq
- PCVX Nasdaq
- Market Cap
- KVYO 8.8B
- PCVX 9.6B
- IPO Year
- KVYO 2023
- PCVX 2020
- Fundamental
- Price
- KVYO $25.65
- PCVX $30.65
- Analyst Decision
- KVYO Buy
- PCVX Strong Buy
- Analyst Count
- KVYO 20
- PCVX 9
- Target Price
- KVYO $47.30
- PCVX $136.50
- AVG Volume (30 Days)
- KVYO 1.8M
- PCVX 3.7M
- Earning Date
- KVYO 05-06-2025
- PCVX 05-07-2025
- Dividend Yield
- KVYO N/A
- PCVX N/A
- EPS Growth
- KVYO N/A
- PCVX N/A
- EPS
- KVYO N/A
- PCVX N/A
- Revenue
- KVYO $937,464,000.00
- PCVX N/A
- Revenue This Year
- KVYO $26.40
- PCVX N/A
- Revenue Next Year
- KVYO $21.94
- PCVX N/A
- P/E Ratio
- KVYO N/A
- PCVX N/A
- Revenue Growth
- KVYO 34.29
- PCVX N/A
- 52 Week Low
- KVYO $21.26
- PCVX $27.66
- 52 Week High
- KVYO $49.55
- PCVX $121.06
- Technical
- Relative Strength Index (RSI)
- KVYO 32.99
- PCVX 26.64
- Support Level
- KVYO $25.95
- PCVX $28.58
- Resistance Level
- KVYO $28.26
- PCVX $32.72
- Average True Range (ATR)
- KVYO 1.95
- PCVX 3.75
- MACD
- KVYO 0.05
- PCVX 0.12
- Stochastic Oscillator
- KVYO 20.93
- PCVX 29.09
About KVYO Klaviyo Inc. Series A
Klaviyo Inc is a technology company that provides a software-as-a-service (SaaS) platform to enable its customers to send the right messages at the right time across email, short message service, and push notifications, more accurately measure and predict performance, and deploy specific actions and campaigns. The platform combines proprietary data and application layers into one solution with machine learning and artificial intelligence capabilities. It is focused on marketing automation within eCommerce as its first application use case. It generates revenue through the sale of subscriptions to its customers for the use of its platform. Geographically, the company generates the majority of its revenue from the Americas, followed by EMEA and APAC.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.